Research Focus

Former Employee. HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM; NE Agency Contingent

Recent additions – View all

1. Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response

   Meeting Abstract

   Dong, L.; Choi, H.; Budhu, S.; Mehanna, N.; Falik, N.; Rosen, N.; Merghoub, T.; Wolchok, J. D.
   Journal of Immunology (2020)

   Fulltext@MSK | Save